Table 3.
Logistic regression analysis of factors associated with headache diary use.
| Factor | Univariate logistic regression | Multivariate logistic regression | ||||
|---|---|---|---|---|---|---|
| OR | 95% CI | P value | OR | 95% CI | P value | |
| Age | 0.992 | 0.98–1.01 | 0.269 | - | - | - |
| Sex (female) | 3.541 | 1.32–12.24 | 0.022 | 8.385 | 2.45–35.75 | < 0.002 |
| Education (higher) | 1.112 | 0.76–1.63 | 0.594 | - | - | - |
| Living in a capital/district center | 1.731 | 1.08–2.84 | 0.025 | 2.081 | 1.19–3.75 | 0.012 |
| Having a child | 0.613 | 0.46–0.80 | < 0.001 | 0.631 | 0.45–0.87 | 0.006 |
| Digital literacy | 1.122 | 1.02–1.23 | 0.023 | 1.195 | 1.07–1.34 | 0.003 |
| Experience in telemedicine | 2.334 | 1.75–3.12 | < 0.001 | 1.687 | 1.21–2.36 | 0.002 |
| Chronic migraine | 5.232 | 2.89–10.03 | < 0.001 | 2.962 | 1.40–6.63 | 0.006 |
| Monthly headache days | 1.053 | 1.02–1.08 | < 0.001 | 1.011 | 0.98–1.05 | 0.535 |
| Migraine without aura | 2.801 | 2.10–3.74 | < 0.001 | 2.171 | 1.55–3.04 | < 0.001 |
| Migraine pain intensity when medications are ineffective | 1.072 | 0.98–1.16 | 0.124 | - | - | - |
| CGRP monoclonal antibodies | 8.463 | 5.48–13.48 | < 0.001 | 6.596 | 4.06–11.04 | < 0.001 |
| Antiepileptic medications | 3.724 | 1.23–13.64 | 0.028 | 5.531 | 1.55–23.27 | 0.012 |
| Triptans | 3.462 | 2.52–4.80 | < 0.001 | 1.966 | 1.37–2.84 | < 0.001 |
| Beta blockers | 1.843 | 1.16–2.92 | 0.010 | 1.264 | 0.73–2.19 | 0.402 |